Edition:
United Kingdom

Five Prime Therapeutics Inc (FPRX.OQ)

FPRX.OQ on NASDAQ Stock Exchange Global Select Market

20.05USD
15 Dec 2017
Change (% chg)

$-0.84 (-4.02%)
Prev Close
$20.89
Open
$21.00
Day's High
$21.15
Day's Low
$19.73
Volume
1,535,188
Avg. Vol
204,700
52-wk High
$53.89
52-wk Low
$19.73

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Lewis Williams

67 2016 Chairman of the Board, President, Chief Executive Officer

Marc Belsky

61 2013 Chief Financial Officer, Senior Vice President

Aron Knickerbocker

47 2016 Chief Operating Officer, Director

Kevin Baker

56 2016 Senior Vice President, Development Sciences

Helen Collins

54 2017 Senior Vice President and Chief Medical Officer